On Tuesday, Third Harmonic Bio Inc (NASDAQ: THRD) was -4.44% drop from the session before settling in for the closing price of $10.80. A 52-week range for THRD has been $8.07 – $16.94.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
When this article was written, the company’s average yearly earnings per share was at -41.99%. With a float of $17.43 million, this company’s outstanding shares have now reached $44.73 million.
Let’s look at the performance matrix of the company that is accounted for 30 employees. In terms of profitability, gross margin is 95.57%, operating margin of -6320.33%, and the pretax margin is -4688.76%.
Third Harmonic Bio Inc (THRD) Insider Updates
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Third Harmonic Bio Inc stocks. The insider ownership of Third Harmonic Bio Inc is 61.32%, while institutional ownership is 39.99%. The most recent insider transaction that took place on Nov 08 ’24, was worth 31,755. In this transaction Chief Medical Officer of this company sold 2,117 shares at a rate of $15.00, taking the stock ownership to the 0 shares. Before that another transaction happened on Oct 29 ’24, when Company’s See Explanation of Responses sold 1,000,000 for $14.30, making the entire transaction worth $14,300,000. This insider now owns 176,692 shares in total.
Third Harmonic Bio Inc (THRD) Performance Highlights and Predictions
According to the Wall Street analysts, stocks earnings will be around -41.99% per share during the next fiscal year.
Third Harmonic Bio Inc (NASDAQ: THRD) Trading Performance Indicators
You can see what Third Harmonic Bio Inc (THRD) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 42.50.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.96, a number that is poised to hit -0.35 in the next quarter and is forecasted to reach -1.44 in one year’s time.
Technical Analysis of Third Harmonic Bio Inc (THRD)
Third Harmonic Bio Inc (NASDAQ: THRD) saw its 5-day average volume 0.21 million, a positive change from its year-to-date volume of 0.15 million. As of the previous 9 days, the stock’s Stochastic %D was 18.80%. Additionally, its Average True Range was 0.94.
During the past 100 days, Third Harmonic Bio Inc’s (THRD) raw stochastic average was set at 5.47%, which indicates a significant decrease from 11.34% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 57.34% in the past 14 days, which was lower than the 71.95% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $12.61, while its 200-day Moving Average is $12.24. Nevertheless, the first resistance level for the watch stands at $10.78 in the near term. At $11.25, the stock is likely to face the second major resistance level. The third major resistance level sits at $11.64. If the price goes on to break the first support level at $9.92, it is likely to go to the next support level at $9.53. Assuming the price breaks the second support level, the third support level stands at $9.06.
Third Harmonic Bio Inc (NASDAQ: THRD) Key Stats
There are 45,058K outstanding shares of the company, which has a market capitalization of 465.00 million. As of now, sales total 0 K while income totals -30,820 K. Its latest quarter income was 0 K while its last quarter net income were -13,800 K.
